Facebook Linkedin Twitter
Inside Precision Medicine Boehringer Acquires Nerio with Its Novel Checkpoint Inhibitors for $1.3B

Boehringer Ingelheim

Immune checkpoint inhibitors: Interaction between PD-1 and PD-L1 blocked by therapeutic antibodies
News & Features

Boehringer Acquires Nerio with Its Novel Checkpoint Inhibitors for $1.3B

0
Multiple Sclerosis Nerve Disorder illustrated as a head with neurons fluorescing in the brain and damaged neurons to the right hand side
News & Features

SEQSTER Chosen to Drive Forward MS Care

0
A machine learning algorithm can predict whether people with major depression will respond to a common antidepressant after only 1 week.
Informatics

Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment

0
Escherichia coli bacteria
News & Features

Boehringer and Ginkgo Ink Potential $400M+ Metagenomics Deal for “Undruggable” Targets

0
Boehringer Ingelheim, Seqster Collaborate on Patient-Centered Clinical Data Tool
Informatics

Boehringer Ingelheim, Seqster Collaborate on Patient-Centered Clinical Data Tool

0
Bacteria on the intestinal epithelium surface, illustration
News & Features

Antimicrobial Resistance Joint Venture Launched by Boehringer Ingelheim, Evotec, bioMérieux

0
Little girl receives breathing treatment
News & Features

Boehringer Ingelheim Enters CF Gene Therapy Development Pact

0
Boehringer Ingelheim will apply Philogen’s Encoded Self-Assembling Chemical (ESAC) Library Technology in the companies' second drug discovery collaboration. [Theasis/iStock Photos]
Molecular Dx

Boehringer Ingelheim to Leverage Philogen’s DNA-Encoded Library Platform

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine